Azab, B., Amundson, J. R., Cioci, A., Stuart, H., Yakoub, D., Avisar, E., . . . Franceschi, D. (2021). The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1–3 Triple Negative Breast Cancer Patients. Breast Care (Basel).

Azab, Basem, Julia R. Amundson, Alessia Cioci, Heather Stuart, Danny Yakoub, Eli Avisar, Fredrick Moffat, Alan S. Livingstone, و Dido Franceschi. "The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio As a Predictor of the 5-Year Survival in Stage 1–3 Triple Negative Breast Cancer Patients." Breast Care (Basel) 2021.

Azab, Basem, et al. "The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio As a Predictor of the 5-Year Survival in Stage 1–3 Triple Negative Breast Cancer Patients." Breast Care (Basel) 2021.